Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Kesin Pharma Announces FDA Approval and U.S. Availability of LIKMEZ™ (metronidazole) Oral Suspension
Wednesday, November 15, 2023Kesin Pharma Corporation a pharmaceutical company focused on innovative Specialty brands and Unit Dose formulations announced today that the US Food and Drug Administration has approved LIKMEZ
Prange Group and Adragos Pharma to Acquire Fresenius Kabi’s Manufacturing Site in Halden, Norway
Wednesday, November 15, 2023Prange Group and its affiliate Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for the acquisition of the leading sterile pharmaceutical production site in Halden
Ocugen Initiates Phase 1/2 Trial for OCU410ST Gene Therapy in Stargardt Disease
Tuesday, November 14, 2023Ocugen Inc a biotechnology company focused on discovering developing and commercializing novel gene and cell therapies biologics and vaccines today announced that the first patient has been dosed in its Phase GARDian clinical trial for OCUST
Sandoz Inaugurates New Antibiotic Production Plant in Austria and New Biosimilar Development Center in Germany
Monday, November 13, 2023Sandoz the global leader in generic and biosimilar medicines has opened two new European facilities in line with its ongoing plans to strengthen sustainable development and supply of critical medicines in Europe and beyond
Novo Nordisk Invests More Than 42 Billion Danish Kroner in Expansion of Manufacturing Facilities in Kalundborg, Denmark
Saturday, November 11, 2023Novo Nordisk today announced plans to invest more than billion Danish kroner starting in to expand existing manufacturing facilities in Kalundborg Denmark for the current and future product portfolio within serious chronic diseases
Bayer and Recursion Focus Research Collaboration on Oncology
Friday, November 10, 2023Bayer and USbased Recursion Pharmaceuticals Inc a clinical stage TechBio company decoding biology to industrialize drug discovery
Revolution Medicines Completes Acquisition of EQRx
Friday, November 10, 2023Revolution Medicines Inc a clinicalstage oncology company developing targeted therapies for RASaddicted cancers today announced it has closed its acquisition of EQRx Inc
Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
Thursday, November 09, 2023Natera Inc a global leader in cellfree DNA testing today announced its personalized and tumorinformed molecular residual disease test Signatera will be used in a new breast cancer study called TREAT ctDNA
Alfasigma Completes Acquisition of Intercept Pharmaceuticals, Inc.
Thursday, November 09, 2023Alfasigma SpA and Intercept Pharmaceuticals Inc announced today the completion of the acquisition of Intercept by Alfasigma through its wholly owned subsidiary Interstellar Acquisition Inc
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
Wednesday, November 08, 2023Evotec SE and Dewpoint Therapeutics today announced a strategic RD collaboration to advance Dewpoints leading oncology pipeline programs of condensate modifying therapeutics
